Cheol-young S. Park
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 237 publications
Efficacy and safety of anagliptin added to metformin and empagliflozin 25 mg in patients with type 2 diabetes: a 24-week randomized, double-blind, placebo-controlled phase 3 trial with 28-week open-label extension.
Journal: Diabetes research and clinical practice
Published: March 22, 2026
Hypertriglyceridemia in adults with diabetes mellitus in Korea: Sex, age, and lifestyle determinants.
Journal: Journal of clinical lipidology
Published: January 02, 2026
Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study).
Journal: Diabetes, obesity & metabolism
Published: September 28, 2025
Hepatorenal vulnerability flagged by glomerular hyperfiltration in metabolic liver disease: a large health-screening cohort evidence.
Journal: Diabetology & metabolic syndrome
Published: September 15, 2025
Correction: Use of an insulin titration protocol based on continuous glucose monitoring in postoperative cardiac surgery patients with type 2 diabetes and prediabetes: a randomized controlled trial.
Journal: Cardiovascular diabetology
Published: September 13, 2025
All-Cause Mortality and Secondary Malignancy in Patients with Pheochromocytoma/Paraganglioma.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: August 26, 2025
Reduced risk of hepatocellular carcinoma in the use of fibrate as an add-on to statin: A retrospective population-based cohort study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 25, 2025
From Old to New: A Comprehensive Review of Obesity Diagnostic Criteria and Their Implications.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: August 04, 2025
Effects of cilostazol on the prognosis of lower extremity peripheral arterial disease in patients with diabetes mellitus in Korea: A nationwide population-based study.
Journal: Atherosclerosis
Published: August 02, 2025
Transcriptomic and metabolomic analyses reveal that lobeglitazone ameliorates hepatic steatosis in rats concurrent with regulation of mitochondrial pyruvate metabolism.
Journal: British journal of pharmacology
Published: July 25, 2025
Understanding the Electrocatalytic Trend of Sulfur Reduction Reaction and Design Rules of Advanced Electrocatalysts for Li-S Batteries.
Journal: ACS nano
Published: July 25, 2025
Lobeglitazone improves glycaemic control as add-on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double-blind, randomised, placebo-controlled trial.
Journal: Diabetes, obesity & metabolism
Published: July 05, 2025
Last Updated: 09/26/2026